With vaccines forthcoming for most Americans, many groups, including expectant mothers, are wondering if the vaccine is safe for them and their babies. A physician-scientist explains.
Academic rigour, journalistic flair
Articles on Immune system
Displaying 61 - 80 of 267 articles
The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
The side effects of new SARS-CoV-2 vaccines are a result of immune system activation. While uncomfortable, they are both normal and expected. They are a sign that the vaccine is working.
Several new studies show our immune responses to the virus can last at least eight or nine months, and probably longer.
There is now a third vaccine that prevents COVID-19 infections. It isn’t quite as effective as the other two vaccines but it has advantages that may make it the frontrunner.
Older adults, who are at a higher risk for COVID-19 complications, can strengthen their immune systems by exercising.
Two pharma companies have announced early COVID-19 vaccine trial results with over 90 per cent effectiveness. What does that mean for getting back to normal?
Anti-complement drugs have shown promise in treating COVID in several small trials. Larger trials are now underway.
Are antibodies that attack a patient’s own organs contributing to severe forms of COVID-19? A new study suggests specific antibody tests that may reveal the answer.
Any COVID-19 vaccine is likely to be given first to higher risk groups before it is given to children. But we still need vaccines that are safe and effective for them too.
Reports of reinfection shouldn’t be cause for alarm. If we gather the right data, they can teach us a lot about the immune response.
Man-made chemical disrupt the activities of most human genes. What effect does this have on human health and how should regulators respond?
Vaccines work by teaching your immune system about new viruses. Your immune cells are very clever – they will remember what they learnt, and protect you if you encounter that virus in the future.
Patients suffering from severe COVID-19 may be experiencing a rogue antibody response similar to that seen in autoimmune diseases. The findings offer new approaches for COVID-19 therapy.
Our first exposure to a pathogen, either naturally or via vaccination, can affect how our immune system responds in the future to the same or similar pathogens.
The president and first lady Melania Trump have both tested positive for the coronavirus. Here’s what the physicians and scientists know about the best treatments for the disease it causes.
Older coronavirus patients face grimmer outlooks. A virologist explains the aging-related changes in how immune systems work that are to blame.
Antibodies are great for neutralizing viruses. But they are big and bulky. Antibody engineers are now creating smaller synthetic antibody-like molecules that may be better for fighting COVID-19.
Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?
Many of us don’t get an adequate amount of nutrients.
Job Board
-
Union Organiser
-
Senior Manager, Student Recruitment (Offshore)
-
Centre of Excellence Chief Operating Officer, Quantum Biotechnology (QUBIC)
-
Director, Monash University Museum of Art (MUMA)
-
Data and Multimedia journalist
Top contributors
-
Professor of Medicine, University of Virginia
-
Professor in Biomedical Sciences, University of Manchester
-
Instructor of Human Immunology, Emory University
-
Senior Research Fellow; Rheumatology Research Group, Centre for Inflammatory Diseases, Monash University
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Research Fellow, Institute for Molecular Bioscience, The University of Queensland
-
Professor of Immunology, University of Manchester
-
Ecologist and Researcher, Flinders University
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Professor, Biomedicine Discovery Institute, Monash University
-
Professor, University of Adelaide
-
Professor of Immunology and Pro Vice-Chancellor, Research Partnerships, Victoria University
-
Immunology researcher, Monash University
-
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
-
Research Scientist and Principal Investigator at the Vaccine and Infectious Disease Organization, University of Saskatchewan
